Korus Pharmaceutical

Korus Pharm is a South Korean pharmaceutical company and a subsidiary of GL Rapha, specializing in the development, manufacturing, and distribution of a wide range of pharmaceutical products. The company produces generic drugs, biosimilars, and provides contract manufacturing (CMO) services for global markets. Korus Pharm gained significant international attention for its role in the production of the Sputnik V COVID-19 vaccine through a consortium. Its portfolio includes treatments for cardiovascular, gastrointestinal, and infectious diseases, as well as various biotechnological products. The company operates multiple manufacturing facilities in South Korea, including sites in Chuncheon and Jecheon, which are equipped for both chemical synthesis and biological production. Korus Pharm continues to expand its global footprint through exports and strategic partnerships in the Middle East, Russia, and Southeast Asia.